Synaptogenix News - SNPX

Company Name	Stock Ticker Symbol	Market	Type
Synaptogenix Inc	SNPX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.01	-0.22%	4.55	11:47:54

Open Price	Low Price	High Price	Close Price	Prev Close
4.45	4.45	4.60		4.56

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/2024	09:15	PRNUS	Synaptogenix Regains Compliance with Nasdaq Minimum Bid..
4/09/2024	09:15	PRNUS	Synaptogenix Increases Stake in Innovative Psilocybin Drug..
4/03/2024	08:00	PRNUS	Synaptogenix Announces Reverse Stock Split to Maintain..
2/06/2024	10:16	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
12/21/2023	17:00	EDGAR2	Form 8-K - Current report
12/19/2023	09:00	PRNUS	Synaptogenix President Daniel L. Alkon, M.D. Honored for..
12/06/2023	09:00	PRNUS	Synaptogenix Joins Leading Neuroscientists and Academics as..
11/14/2023	17:05	EDGAR2	Form ARS - Annual Report to Security Holders
11/13/2023	17:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/06/2023	17:00	EDGAR2	Form 8-K - Current report
11/03/2023	17:00	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/02/2023	09:00	PRNUS	Synaptogenix Acquires Significant Stake in Cannasoul..
9/26/2023	09:00	PRNUS	Synaptogenix Announces Peer-Reviewed Publication of..
9/22/2023	16:05	EDGAR2	Form 8-K - Current report
9/07/2023	09:00	PRNUS	Bryostatin-1 from Synaptogenix Shows Statistically..
8/14/2023	17:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/19/2023	09:00	PRNUS	Synaptogenix and Cleveland Clinic to Submit Investigational..
7/19/2023	08:55	EDGAR2	Form 8-K - Current report
7/13/2023	09:00	PRNUS	Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in..